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Abstract 
The le,els of endothehn-1-like tmmunoreacu' ny (ET-1-LI) and 
characteristics of endothelin receptors in the choriomc villous tissue of 
human placenta were determined. The ET -1-LI levelm chorionic vtllous 
tissue obtained from normal term placenta was 2,4.50 ± 940 pg/ g wet 
weight (mean± SD, n = 4). Further analysis using gel permeation 
chromatography and reverse-phase high performance liquid 
chromatography showed that the mam ET-1-LI constituent of this tissue 
was ET -1. Scatchard analysis of [125I]ET -1 binding to the membrane 
fraction of chorionic villous tissue obtained from term placenta showed high 
affinity receptor sites with an apparent dissociation constant (Kd) of 23.6 ± 
11.1 pM and Bmax value of388 ± 238 fmol/mg protein (n=S). The same 
binding study with [125I]ET -3 showed a Kd of 13.9 ± 3.8 pM and a Bmax 
value of 176 ± 78 fmollmg protein (n=S). These results suggest that both 
ET-A and ET -B receptors (ET -AR and ET -BR) are expressed m chonoruc 
villous tissue. This finding was further confirmed by Northern blot 
analysis showing the expression of both ET -AR and ET -BR mRNAs in th1s 
tissue. 
ET -1-LI in the umbilical venous plasma of the newborns from 
women with pregnancy-induced hypertension (PII-1) (38.3 ± 10.4 pg/mL, 
n=S) was significantly (P < 0.05) higher than that in the normal newborns 
from normotensive pregnant women (26.3 ± 5.2 pg/mL, n= 12). However, 
in placental chorionic villous tissue obtained from PIH women, both ET-1-
LI level and ET binding profile were not different from those m chononic 
villous tissue from normotensive pregnant women. 
These results suggest that the abundant ET-ET receptor system IS 
present m the placental chorioruc villous tissue and that this system IS not 
the major factor of the pathogenesis of placental dysfunction occurring in 
Hase!Zawa et al. Pa!le 3 
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PIH because these systems are s1m1lar m normotensl\e and hypertensive 
pregnanc1es. 
Kev words: endothelin, endothelin receptor, ~orthern blotting, placenta, 
pregnancy-induced hypertension. 
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Introduction 
Endothelin (ET) is a potent' asoconsuictor peptide originally 
ISolated from the culture medium of porcine aortic endothehal cells [36). 
Three dtstinct ET -related genes have been Identified from a human genomtc 
~ ~ 
D~A library and the corresponding peptides were designated as ET -1, ET-2 
and ET -3 [12). To date, ET -1 has been found to be secreted by a \.vide 
variety of cells including human breast epithelial cells [2], human 
macrophages [6], human amnion cells [8, 31), and human placenta [12, 
22]. ET has been postulated to be involved in the pathophysiological 
mechanisms of essential hypertension [25], cerebral vasospasm after 
subarachnoid hemorrhage [28], renal failure (15) and pulmonary 
hypertension [36). In pregnant women with pregnancy-induced 
hypertension (PIH), plasma ET level has been reported to be increased 
compared to that in normotensive pregnant women [5, 11, 13, 17, 20, 28, 
32). 
Recently, cDNAs encoding two distinct subtypes of ET receptor 
were cloned and termed ET -AR (ET -1-selecttve type) and ET -BR (non-
isopeptide-selective type) [1, 10, 21, 36]. ET-1 binding sites were reported 
to be present in the fete-placental vessels of normal pregnancy [9, 23]. In 
pregnancy complicated with intrauterine growth retardation (IuGR), ET -1 
binding characteristics of fete-placental vessels were not different from 
those in normal pregnancy [18). However, the involvement of ET and ET 
receptors in chorionic villous tissue in the placental dysfunction of PIH has 
not yet been determined. In the present study, to elucidate the posstble role 
of placental endothelin in the pathophysiology of PIH, the concentration of 
ET and 1ts receptors m the placental chorioruc villous tissue, as \veil as ET 
concentration in the umbilical venous plasma of the newborns, were 
determined in normal and PIH pregnancy. 
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Materials and Methods 
Sub jects: Placentae were obta.med from four pregnant women with PIH 
who had undergone Cesarean section due to fetal distress (mean:::: SD of 
gestatwnal age; 36.2 ± 4.3 weeks), and five normal pregnant women who 
had undergone elective repeat Cesarean section (gestanonal age; 38.7 ± 1.1 
weeks). Fetal distress was diagnosed by abnormal findings in FHR-
monitonng and pulsed Doppler blood flow velocity waveform analys1s of 
fetal descending aorta All Cesarean sections were performed before the 
onset of active labor. After removal of macroscopic clot and attached 
decidua, choriomc villous ussue was separated from primary stem vessels 
and snap-frozen in the liquid nitrogen, and then stored at -70 °C. First 
tnmestcr chonomc villi were obtained from five pregnant women at the time 
of legal induced abortion performed at eighth to tenth week of gestation, 
and processed as described above. The whole procedure of sampling was 
completed within 15 min from recovery of the tissue. 
Umbilical venous blocx:i was obtained at the time of elective 
Cesarean sections from five pregnant women with PIH (gestational age; 
35.8 ± 3.6 weeks), including the above mentioned four women, and from 
12 normotensive pregnant women who had undergone elective repeat 
Cesarean section (gestational age; 38.7 ± 1.3 weeks). Informed consent 
was obtamed from each patient. Clinical data from patients with PIH are 
listed in table 1. 
Blood sampling and extraction: 10 mL of umbilical cord blood was 
tmmediately mt\.ed \Vith 1 mL of saline solutiOn containing 10 mg of EDTA 
and 10,000 KIU of aprotmin, and was centrifuged at 2,000 x gat 4 °C for 
LS mm. Plasma samples\\ ere stored at -20 oc until assayed. ET -1-LI was 
e\.tracted from plasma samples usmg pol: styrene beads coated \\ith 
monoclonal anu-ET -1 antibody as described preYiously [24]. 
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Radioimmunoassay for ET-1: Radwunmunoa.ssa: (RIA) for ET-1 \t.as 
performed usmg an ant1-ET -1 monoclonal antibody as descnbed previOusly 
[8, 2-+, 36]. The cross-rcacU\ltles of the anubcx:i) (KY -ET -1-IV) for IT -:2. 
ET-3 and bigET -1 were 80%, 20% and 80% on a molar basis. respect1 vel :y. 
The sensitivity of this RIA was 0.2 pgltube, and the soq; inhibltOIJ 
concentration was 2 pg/tube. Intra- and interassay coefficients of vanatwn 
were 7.2% (n = 20) and 11.6% (n = 20), respectively. 
Tissue extraction: Chorionic VIllous tissues \'\ere weighed and 
homogenized using a Poiytron homogenizer for 1 min (settmg 7) in lO 
volumes of ice-cold 1N acetic actd contammg 0.1% Tnton X-100 as 
previously described [30). Homogenates were then boiled at 95 oc for7 
min to inactivate proteases. After centrifugation at 30,000 x g for 30 min at 
4 °C, the supernatant was stored at -20 oc until assay. ET-1-LI in the 
supernatant was subjected to RIA as described above without further 
extraction. 
Gel permeation chromatography (GPC): Tissue homogenatcs were 
extracted using Sep-pak C-18 columns (Waters Assoc., Milford, M.A.) and 
were applied to a Sephadex G-50 column at 4 oc as descnbcd [24]. The 
column was calibrated with blue dextran, human bigET -1, and ET -l. ET -1-
LI in each fraction was measured by RIA. 
Reverse-phase high performance liquid chromatography (RP-
HPLC): Peak GPC fractions were re-extracted using Sep-pak C-18 
columns and applied to an octadecyl-silica column (CLC-ODS 0.6 x 15 
em, Shtmadzu, Kyoto, Japan) at 30 oc and eluted at a flow rate of 1 
mUm in \\'ith a linear gradient of acetomtnle in 0.1% trifluoroacenc acid. 
One mL fractions were collected and ET -1-LI in each fraction was measured 
by RIA. 
Ligand binding assav: Chonoruc qllous tissues \\ere homogenized 
using a Polytron homogenizer (setting 7) three times for 15 sec each time In 
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10 volumes of ice-cold homogenization buffer containing 50 mM Tris 
(pH7.5), 0.1 mM EGT A, 154 mM NaCl, 10 ,ug/mL pepstatin, 10 ,ug/mL 
leupeptin, 100 ,uglmL phenylmethylsulphonylfluoride (PMSF), and 10 
,uglmL aprotinin (6,400 KIU/mg tissue). The homogenate was centrifuged 
at 1,000 x g for 30 min at 4 °C, and the supernatant was centrifuged at 
40,000 x g for 30 min at 4 oc. The resulting pellet was washed twice and 
the pellet of the final centrifugation was then resuspended in the same buffer 
at a final protein concentration of 0.5-1.0 mg/mL and stored at -70 oc until 
assay. Protein concentration was measured by the method of Bradford et 
al. (4]. 
Aliquots of membrane suspension of chorionic villous tissue were 
incubated in receptor assay buffer (25 mM Hepes in Hanks' balanced salt 
solution, pH 7.0) containing 0.2% BSA (Sigma, St. Louis, MO), 10 
ytglmL pepstatin, 10 ,ug/mL leupeptin, 100 ytglmL PMSF and 10 ,ug/mL 
aprotinin with varying amounts (2- 128 pM) of [l25I]ET -1 or [l25I]ET -3 
(2,000 Ci/mmol, Amersham, Buck.inghamshire, U.K.) for 90 min at 25 oc 
(total volume 250 ,uL). The reaction was stopped by chilling in an ice-cold 
water bath. Membrane-bound radioactivity was separated from free ligands 
by rapid filtration through Whatman GF/C glass fiber filters and the 
radioactivity associated with the filters was measured with a gamma counter 
at 60% efficiency. Specific binding was defined as the difference between 
the total binding and the nonspecific binding determined in the presence of 
100 nM unlabeled ET -1 or ET -3. 
Total RNA extraction and Northern blot analysis: Total RNA was 
extracted from chorionic villous tissue by the guanidinium thiocyanate/CsCl 
method [27]. Total RNA (20 ytg) was fractionated on a 0.66 M 
formaldehyde-!% agarose gel, transferred on to a nylon membrane and 
h\·bridized \Yith 32P-labeled human ET -AR and ET -BR eDNA fra2:ments as 
- .... 
pre,·iously described [10, 21]. 
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Statistical analysis: Data are expressed as the means± SD. Statistical 
comparisons between the groups were carried out by Student's t test. p 
values less than 0.05 were regarded as significant. 
r 
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Resu lts 
ET-1-Litn the umbilical venous plasma of newborns from PIH 
\~Omen was 38.3 ± 10.4 pgtmL (n = 5), significantly h1gher than that of 
newborns from normotensive pregnant women (26.3 ± 5.2 pg mL, n = 12, 
p < 0.05). 
ET -1-Ll m the homogenate of chorioruc villous tissue was 
measured by RIA. The senal dilution curve of extracts of chononic villous 
tissue paralleled to the standard curve of ET -1 (data not shown). Figure 1 
shows a comparison of ET -1-Lilevels in the homogenates of first trimester 
chonoruc villous ussue, and tlurd trimester chorionic villous tissues 
obtained from nonnotensive and PIH women. ET-1-LI level in the 
homooenates of chorionic villous tissue in the first trimester was 210 ± 68 
0 
pg/g wet weight (n = 5). A strikingly high level of ET -1-LI was observed 
in homogcnates of chorionic villous tissues from normal pregnant women at 
tenn (2,450 ± 940 pg/g wet weight, n = 4) and in those from women with 
PIH (2,850 ± 740 pg/g wet weight, n = 4), but these values were not 
stgnificantly different from each other. 
Figure 2 shows a typical GPC profile and RP-HPLC pattern of ET-
1-LI in homogenates of choriomc villous tissues from women complicated 
\vtth PIH. As shown in Figure 2(A), ET -1-LI in the chorionic villous 
tissue from PIH-complicated pregnancies was predominantly eluted at the 
same position as synthetiC ET-1 (n = 2). ET-1-LI in this peak fraction was 
further analvzed bv RP-HPLC. in which ET-1-LI \\·as mainlv eluted at the 
. . . 
same position as synthetic ET -1 (Figure 2(8)). Several minor peaks were 
also obsen ed, all of wh1ch were at positions different from any synthetic 
ETs. Exactly equi,·alent paHerns \\·ere obsened in GPC and RP-HPLC 
profiles of ET -1-LI in homogenates of chorionic ,.illous tissue of nonnal 
term placentae (n = 4. data not shO\Yn). 
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Li2and bmdm2 analvscs for [1:5J]ET -1 and [l:SI]ET-3 were 
.... ... . 
earned out using membrane fractions of placental chorioruc villous tissue. 
Bmding of [125J]ET-1 and [!25J]ET-3 to the placental membrane fraction 
reached an apparentequilibnum after 90 mm mcubauon at25 oc (data not 
sho\vn). Figure 3 illustrates typical saruratton bmdmg isotherms and 
Scatchard plots of [125J]ET -1 and [125J]ET -3 to the membrane f racuon of 
chorioruc villous tissue obtained from normotensive pregnancy. Table 2 
summarizes the apparent Kd and Bma"" values for [125I]ET -1 and [125J]ET-
3. In the chorionic villous tissue of term placentae from normotensive 
women, a single class of high affinity ET -receptor sites wtth apparent Kd of 
23.6 ± 11.1 pM and Bmax value of 388 ± 238 fmollmg protein for 
[125I]ET-1 were identified (n = 5). The Kd and Bmax values for [125I]ET-
3 were 13.9 ± 3.8 pM and 176 ± 78 fmollmg protem (n = 5), respectively. 
In the chorionic villous tissue of placentae from women complicated with 
PIH, Kd values for both [125J]ET -1 and [125f]ET-3 were almost tdentical to 
those in normotensive pregnant women. Bmax values for [I 25I]ET -1 and 
[125I]ET-3 (263 ±51 fmol/mg protem and 127 ± 21 fmol/mg protem, 
respectively) were slightly lower than those in the chorionic villous ttssue of 
normotensive pregnant women. However, the differences were not 
statistically Significant. Although the ET concentration in the first tnmester 
chorionic villous tissue was extremely low, the Bmax value in this tissue 
was comparable to that in the chorionic villous tissue of term placentae. 
The ratio of Bma"" value for [125I]ET-3 to that for [125J]ET-l were Stmtlar 
in both normal and PIH placentae (Table 2). 
As shown in Figure 4, Northern blot analysis using human ET-AR 
and ET -BR eDNA probes detected substantial levels of both Ef-AR and 
ET -BR mR"iAs in choriomc ,·illous ussues of tenn placenta and 10 the first 
trimester chorionic 'illous tissue; a smgle 4.3 kb band and t\vo bands of 4.3 
kb and 1.7 kb "ere detected, respecttYely. 
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Discussion 
In the present study, we observed a high concentrauon of ET -1 
(approxJmatel] 1 pmol g wet we1ght) in the chorioruc villous nssue of 
human placenta at term. ET -1 at this concentration has been reported to 
elJcit substantial effects on various cell funcnons including proliferation of 
placental fibroblasts and contraction of cotyledonary vessels [7, 19, 34, 
35]. Thus, it is probable that ET-1 in this t1ssue is of some physiological 
significance. Other ET tsopeptides (ET -2 or ET -3) were not detected in 
term placentae m the present study, although the expression of Ef -3 mRNA 
was reported in this tissue [22]. 
We and others have reported previously that plasma ET-1-LI levels 
in pregnant women with PIH are elevated compared with those in the 
normotensive pregnant women [5, 11, 13, 17, 20, 28, 32], although 
several mvestigators have reported contradictory results [3, 16]. In the 
present study, Ef-1-LI levels in the umbilical venous plasma of newborns 
from PIH women were also higher than those in newborns from 
nonnotensive pregnant women. These findings suggest that the elevated 
levels of plasma ET -1-LI observed on both sides of placental circulation in 
PIH may be a consequence of enhanced ET -1 production in placental tissue, 
which may be related to the central events of this disorder such as reduced 
uteroplacental blood flow and increased placental vascular resistance [14, 
33]. 
In the present study, however, ET-1-LI levels in placentae from 
PIH \\Omen were not different from those m the placentae from 
nonnotensJ\·e pregnant women. Furthennore, the molecular form of ET in 
the placentae of both of these groups were almost identical. These results 
suggest that the mcreases m ET -1-Ll obserYed in the plasma of both mother 
and fetus dunng pregnancy complicated With PIH does not originate from 
the placenta. but may origmate from other' ascular beds or reflect altered 
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ET metabohsm Stmilar findmgs were reported b) Benignt et al. [3], but 
the reported ET concentration and the molecular form of ET were both quite 
different from our data, probabl) due to d1fferences m extractiOn procedures 
between this previous and the present stud;. 
High affinity receptor sHes for [1 25I]ET -1 and [125I]ET -3 were 
detected in membrane preparations from tcnn placentae and first tnmester 
chorioruc tissues. The calculated Bma'< value for [125I]Ef -3 was 
approximately half of that for [125J]ET -1 m both term placentae and first 
trimester chorionic tissues. To date at least two types of Ef receptors, Ef-
AR and ET -BR, have been reported [10,21]. The affinity of ET -3 for 
human ET -AR when expressed in transfcctcd cells ts two orders of 
magnitude lower than that of Ef -1 [10], and the affinities of ET -isopeptides 
for Ef -BR are the same [21]. Thus, the results of the present bindmg assay 
indicate that ET -AR and ET -BR are expressed almost equally in term 
placentae and in first trimester chorionic tissues, provided that ET -AR and 
ET -BR are the only Ef receptors present. Northern blot analysis confirmed 
that Ef -AR and ET -BR genes are expressed m human placentae at term. 
ET -AR and Ef -BR have been reported to be expressed in vascular smooth 
muscle cells and vascular endothelial cells, respectively [10, 21]. Placenta 
has abundant vascular tissue, wruch may become a target of placental 
endothelin. In addition, in our preliminary experiment, the intracellular 
calcium ion concentration of human placental trophoblast cells m pn mary 
culture was increased equally by addition of either ET -1 or ET -3, 
suggesting the presence of ET-BR m these cells (Yano J & Sagawa N, 
unpublished obsen·ation). Thus, It is plaustble that the rugh concentrations 
of ET -1 obserYed in the placenta may bind to the abundant ET receptors 
there and modulate vanous placental functions. 
In the placentae from \\Omen with PIH, Bmax ,·alues for [125I]Ef-
1 and [1 25I]ET -3, and their ratio (Bmax <ET -3> Bmax <ET 1> rauo) were 
Hasegawa et al. Page 13 
essential!) the same as those in normal placentae, suggestrng that the ET 
system in the placenta is not altered in PIH. 
In conclusiOn, an extremely high concentration of ET -1 and 
abundant ET -AR and Ef -BR \\ere tdenttfied in normal human placentae at 
term, suggesting a possible biological role of ET -1 in this tissue. However. 
concentrattons of ET -1 and ET receptors in placentae from PIH women 
were not different from those in the normal placentae. Thus, the elevated 
levels of plasma ET -1-LI observed in both maternal and fetal circulation 
dunng pregnanctes complicated by PIH cannot be related to changes in the 
ET system 10 the placenta. Further investigation of the effects of ET on 
trophoblast function or on placental vascular contraction (tone) may provide 
more information on the physiological and pathophysiological role of the 
ET system 10 the human placenta 
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Table 1. Climcal features of PIH women. 
Case# Gestauonal Panty Blood Unne Birth Deviation Apgar 
age pressure protein WCight from mean score 
(weeks) (mmHg) (g day) (g) birth \:~:eight ( 1 min) 
case 1 31 0 186/116 1 750 -3.1 SD 1 
case2 36 0 219/139 1 1640 -1.8 SD 7 
case 3 35 0 200/110 3 1920 -1.2 SD 6 
case4 41 0 144/102 10 2350 -2.4SD 8 
case 5* 36 0 169/102 3 2166 -1.1SD 8 
*; Placenta was not analyzed in this case. 
Table 2. Bmax and Kd values of [1 25I]ET -1 and [1 25I]ET -3 binding to the membrane 
fractions of chorionic vi llous tissues of first and third trimester of pregnancy. 
Tissue Bma'<(ET -1) Kd(ET -1) Bmax(ET -3) Kd(ET -3) Bmax(ET -3)/ 
(fmol/mg prot.) (pM) (fmollmg prot.) (pM) Bmax(ET-1) ratio 
First tnmester 
Normal 290 ± 171 18.6 ± 2.5 169 ± 78 15.1 ±4.3 0.62 ± 0.12 
(n=S) 
Third trimester 
Normal 388 ±238 23.6 ± 11.1 176 ± 78 13.9 ± 3.8 0.50 ± 0.17 
(n=S) 
PIH 263 ±51 22.6 ±7.6 127 ± 21 14.2 ± 3.3 0.48 ± 0.03 
(n=4) 
Values are the means± SD, 
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Legends for Figures 
Figure 1. Levels of ET -1-LI in the homogenates of first trimester 
chonoruc villous ussue and chononic VIllous ussues from both 
normotensive and PIH women in the third trimester. 
Values are the means± SD. 
Figure 2. Typical GPC profile (A) and RP-HPLC pattern (B) ofET-1-LI 
in the homogenate of chorionic VIllous ussue of term placentae. 
The extract from chorionic villous tissue of PIH-complicatcd 
pregnancy was subjected to GPC and RP-HPLC as descnbed in Materials 
and Methods. Vo, void volume; Vt, total volume. 
Figure 3. Typical saturation isotherms of [ 125I]ET -1 and ( 125r]ET -3 
binding to the membrane fraction of chononic VIllous tissue of normal 
pregnancy at term. 
Membranes (6-9 }Ag protein) were mcubated with various 
concentrations of [125I]ET -1 or ( 125r]ET -3 for 90 min at 25 ·c. 
Nonspecific binding (NSB) was determined by incubation in the presence 
of 100 nM unlabeled ET -1 or ET -3. Scatchard plots of the binding data arc 
shown in the inset. Closed circles; total [125r]ET-1 binding, Closed 
squares; total [ 125J]ET -3 bindmg, Open circles; NSB of [ 125I]ET -1, Open 
squares; NSB of [125r]ET -3. 
Figure 4. Northern blot analysis of total R!\JA from first tnmester 
chorionic tissue and chorionic villous tissues from both normotensn,e and 
PIH women in the third trimester. 
Total RNA (20 }A g) from chorionic ..-illous tissues\\ ere analyzed as 
descnbed in Materials and Methods, 
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Summary 
To elucidate the possible role of endothelin (ET) in the 
pathophysiology of pregnancy-induced hypertension (PIH), the 
concentration of ET and its receptors in the chorionic villous tissue of 
placenta as well as Ef concentration in the umbilical venous plasma from 
normal and PIH-complicated pregnancy were determined. 
Placentae were obtained from four PIH-complicated women who 
had undergone Cesarean section due to fetal distress, and five normal 
pregnant women who had undergone repeat Cesarean sections. Chorionic 
tissue in the first tnmester was obtained from five pregnant women at the 
time of legal induced abortion performed at eighth to tenth week of 
gestation. Umbilical venous blood was obtained from five newborns 
delivered from women with PIH by emergency Cesarean sections due to 
feral distress, and from twelve newborns delivered from normal pregnant 
women by elective Cesarean section before labor onset at term. Ef -1-like 
Immunoreactivity (ET-1-LI) in the tissue homogenate and plasma samples 
were measured by a sensittve RJA as described previously [22]. 
High levels of Ef -1-LI were detected in the chorionic villous tissue of 
term placenta (2,450 ± 940 pg/g wet weight, mean± SD, n = 4) (Figure 1). 
Further analysis using gel permeation chromatography (GPC) and reverse-
phase htgh performance liquid chromatography (RP-HPLC) revealed that 
the main constituent of ET -1-LI in this tissue was ET -1 (Figure 2). 
Scatchard analysis of [125I]ET saturation binding in the chorionic villous 
ussue of term placenta showed linear plots mdicating a single class of 
bmding Sites with apparent dissociation constant (Kd) of 23.6 ± 11.1 pM 
and 13.9 ± 3.8 pM, and Bmax ,·alues of 388 ± 238 fmollmg protein and 
1-6:::-8 fmol/mg protein. for [125f]ET-l and [125r]ET-3 (n=5). 
respecu' ely (table II). Th1s ,,·as supported by the Northern blot analysis 
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'" hich showed that both ET-A and Ef -B receptor genes arc expressed m 
this tissue (Figure 4). 
Comparable Ef receptor sncs and remarkably lower ET -1-LI lc\.els 
were observed in the first trimester chorion (Figure 1, table II). 
In the chononic villous tissue of placenta from PIH-complicatcd 
women, both ET-1-LI and ET binding profiles were not different from 
those in the normal pregnancy (Figure 1, table II), whereas ET -1-LI in the 
umbilical venous plasma from these hypertensive patients (38.3 ± 10.4 
pg/mL, n = 5) were significantly (P<0.05) elevated when compared with 
those in the normal newborns (26.3 ± 5.2 pg/mL, n = 12). 
These results suggest that ET system may not be directly involved 
in the development of placental dysfunction oecumng in Pil-L 
In conclusion, an extremely high concentration of ET -1 and 
abundant ET -AR and ET -BR were identified in the human normal placenta 
at term. However, the elevated levels of plasma ET -1-LI observed in both 
maternal and fetal circulation in pregnancy complicated with PIH could not 
be related with the changes in the ET production or concentrauons of ET 
receptors in the placenta. Further study is mandatory to elucidate the role of 
ET system in the pathophysiology of placenta in PI H. 
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